Chryscapital

With multiple facilities in Bengaluru, Pune and Chennai, Nash Industries serves diverse sectors including automotive, aerospace, defense, healthcare, banking hardware and electrical systems.

ILJIN Electronics secures Rs 1,200 crore funding from ChrysCapital, InCred PE

ChrysCapital will lead the round with an investment of Rs 1,100 crore, while InCred PE will contribute Rs 100 crore.

ChrysCapital buys 85% stake in Theobroma, targets expansion in eastern India

The transaction signals the first buyout in the consumer sector for the private equity firm.

The Sleep Company raises Rs 480 crore in funding led by ChrysCapital, 360 ONE Asset

Moneycontrol was the first to report in April that the firm was in talks with multiple investors for a Rs 500 crore fundraise

SaaS firm MoEngage to raise $200 million from ChrysCapital, A91, Goldman Sachs

The round will be a mix of primary and secondary capital. While the primary component will go towards paying tax to flip back from the US to India, the secondary component will be used to buy shares from some of its early investors

Exit pipeline via IPOs would aggregate to $3 bn plus in next three years, says ChrysCapital’s Sanjay Kukreja

Enterprise tech, pharma/healthcare, consumer and financial services remain the firm’s focus investment areas. Kukreja expect’s $40 bn to $50 bn of just private equity deals in the course of the next 12 months

ChrysCapital said to raise $2.1 billion record buyout fund

The 26-year-old firm’s latest fund is about two-thirds bigger than its last capital raise of $1.25 billion in 2022, and beat the record $1.7 billion raised by India’s Kedaara Capital last year

IPO-bound Credila suspects fraud in loan portfolio, makes Rs 80 crore provision

The suspected fraud cases were detected in the September quarter and are being investigated, the company has said

ChrysCapital-backed pharma firm Corona Remedies plans up to Rs 2,000 crore IPO

ChrysCapital, acquired a 27.5 percent stake in the company in 2021 for an investment of Rs 670 crore.

ChrysCapital sells its stake in GeBBS Healthcare to EQT

The deal offers great market opportunity to offshore vendors such as GeBBS with a broad portfolio of solutions to witness significant tailwinds, driven by cost pressures and lack of talent onshore

ChrysCapital wants bigger share of dessert pie, in talks to acquire The Belgian Waffle Co: Report

The deal could value the nine-year-old firm at Rs 1,300 crore. ChrysCapital has also along with some other PE firms and Switz Group submitted non-binding bids for a majority stake in Theobroma

EQT & Hillhouse seen as frontrunners as sale of ChrysCapital owned GeBBS Healthcare enters final lap

The transaction is likely to value GeBBS Healthcare at around $800 mn. Earlier reports have named private equity firms Caryle and CVC Capital as other interested parties in the deal

Theobroma stake sale: Switz Group, Kedaara Capital, Carlyle, ChrysCapital seek a big bite

On March 8, Moneycontrol reported that key investor ICICI Venture and the promoters of Theobroma had appointed Arpwood Capital to explore the sale of a controlling stake at a targeted valuation around Rs 3,500 crore

IPO-bound Awfis’ Amit Ramani on the startup’s differentiated business model, demand for co-working spaces in India

Post the IPO, Awfis’ largest shareholders Peak XV’s stake will decline to 10-11 percent and ChryCapital’s holdings through its unit Bisque will go down to about 13-14 percent stake, Ramani said.

ChrysCapital invests $100 mn in Centre for Sight, purchases Mahindra Holdings' complete stake

CFS offers a full suite of eye care services, including cataract surgery, LASIK and Smile treatments, treatments for retinal issues and glaucoma, oculoplasty, as well as paediatric eye care

ChrysCapital closes $700-million continuation fund

The new continuation fund, the largest ever in India, acquires stake in NSE

Ontario Teachers and Chrys Capital team up to bid for Healthium Medtech

The transaction is likely to be upwards of Rs 6,000 crore which is almost a three-fold jump in valuation from the acquisition price that Apax Partners paid while acquiring the company in 2018 from TPG Capital.

ChrysCapital to raise $300 million to keep NSE stake

ChrysCapital bought a 5% stake in NSE, one of the largest stock exchanges in the world, in 2016.

ChrysCapital & Peak XV backed Awfis picks 3 i-banks for 2024 IPO; first ever by a co-working space startup

Chennai based Awfis competes with the likes of WeWork, Smartworks and Tablespace. The segment has seen a sharp recovery post Covid-19 with a bulk of the demand coming from the IT sector.

MC Interview | ChrysCapital's Kunal Shroff sees bigger trend of larger stake sales and control deals

ChrysCapital has struck more than 100 deals in India, raised $5 billion over nine funds and returned $6.5 billion to investors. The leading private equity firm backs companies ranging from Lenskart and Bandhan MF to Mankind Pharma and GMM Pfaudler

Why is ChrysCapital excited about the block deal boom?

2023 has been an active year for block deals and according to data from Prime Database, PE and venture capital firms exited investments worth Rs 57,338 crores through block deals between January and August as compared to Rs 41,051 crores during same period last year

ChrysCapital's Kunal Shroff on the India public Vs private strategy, block deal mania & more | Exclusive

On this edition of Deal Central, we put the lens on India's oldest and largest private equity firm ChrysCapital with a rare and exclusive interview with Kunal Shroff, the Managing Partner of the home-grown entity. With over 100 deals struck over 2 decades, $5bn raised over 9 funds and $6.5 bn generated in returns , ChrysCapital backs firms across sectors ranging from Lenskart and Mankind Pharma to GMM Pfaudler and Bandhan Mutual Fund. Shroff believes India has become more attractive for overseas investors with many entrepreneurs gearing up to sell larger stakes and ceding control. Speaking on the ongoing block deal mania in the domestic markets, Shroff says the viability of block trades has increased, even as he adds that some banks are attractively valued in the listed financial services space. Shroff also weighed in on the funding winter in the Indian startup ecosystem and expects more portfolio companies to make market debuts in the next two years.

ChrysCapital joins race to buy Glenmark Life Sciences for around Rs 7,000 cr

The board of Glenmark Pharmaceuticals is said to take a decision regarding the sale soon and the amount received will be used to repay the debt of Rs 2,904 crore

HDFC signs definitive pact with BPEA EQT-led consortium for sale of HDFC Credila for Rs 9,060 cr

On May 22, Moneycontrol was the first to report that a Baring PE EQT-led consortium was the frontrunner to pick up a majority stake of around 90 percent in HDFC Credila.

Lenskart's $600 mn funding gives early investors including SoftBank a big exit

In total, across the two rounds, where Lenskart raised $500 million in March and $100 million now, about $450-500 million was in the form of secondary sales in what was understood to be a mega payday for some early backers of the company.